[StemCyte-KY] Announcement of Board Resolution to Waive Non-Compete Restrictions for Manager at Subsidiary Taiwan StemCyte

Key facts

  • [StemCyte-KY] Announcement of Board Resolution to Waive Non-Compete Restrictions for Manager at Subsidiary Taiwan StemCyte
  • StemCyte-KY announced that the board of its subsidiary, Taiwan StemCyte, resolved to waive non-compete restrictions for General Manager Lu Kung-Ming, allowing him to hold concurrent positions at firms such as Diamond High-Tech Investment and Microbio Shanghai.
  • Source: PR Times
  • Date: May 29, 2026

Direct answer

StemCyte-KY announced that the board of its subsidiary, Taiwan StemCyte, resolved to waive non-compete restrictions for General Manager Lu Kung-Ming, allowing him to hold concurrent positions at firms such as Diamond High-Tech Investment and Microbio Shanghai.

Citation
[StemCyte-KY] Announcement of Board Resolution to Waive Non-Compete Restrictions for Manager at Subsidiary Taiwan StemCyte (May 29, 2026), PR Times
Source
PR Times
Date
May 29, 2026
StemCyte-KY announced that the board of its subsidiary, Taiwan StemCyte, resolved to waive non-compete restrictions for General Manager Lu Kung-Ming, allowing him to hold concurrent positions at firms such as Diamond High-Tech Investment and Microbio Shanghai.
businessNQ 47/100出典：PR Times

📋 Article Processing Timeline

  • 📰 Published: May 29, 2026 at 09:00
  • 🔍 Collected: May 30, 2026 at 08:00 (23h 0m after Published)
  • 🤖 AI Analyzed: May 31, 2026 at 17:35 (33h 35m after Collected)
1. Date of resolution: 115/05/29. 2. Manager: Lu Kung-Ming, General Manager. 3. Permitted activities: Chairman of Diamond High-Tech, Director of Microbio Shanghai, etc. 4. Period: During tenure as manager. 5. Resolution: Approved unanimously by attending directors. 6. Mainland China business: Lu Kung-Ming (Director of Microbio Shanghai). 7. Investment: $5.705 million USD, 10.88% stake. 8. Other: None.

FAQ

What is non-compete for managers?

Legal restriction preventing managers from working for competitors without board approval.

What are the key facts in this article?

StemCyte-KY announced that the board of its subsidiary, Taiwan StemCyte, resolved to waive non-compete restrictions for General Manager Lu Kung-Ming, allowing him to hold concurrent positions at firms such as Diamond High-Tech Investment and Microbio Shanghai.

What is the direct answer?

StemCyte-KY announced that the board of its subsidiary, Taiwan StemCyte, resolved to waive non-compete restrictions for General Manager Lu Kung-Ming, allowing him to hold concurrent positions at firms such as Diamond High-Tech Investment and Microbio Shanghai.

Back to Newsroom (91)